Rhumbline Advisers Harrow Health, Inc. Transaction History

Rhumbline Advisers

$113 Billion
Q2 2025

A detailed history of Rhumbline Advisers transactions in Harrow Health, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 46,969 shares of HROW stock, worth $1.98 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

46,969

Previous 42,975 9.29%

Holding current value

$1.98 Million

Previous $1.14 Million 25.46%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 12, 2025	BUY	$22.2 - $31.61 $88,666 - $126,250	3,994 Added 9.29%	46,969 $1.43 Million
Q1 2025 Apr 08, 2025	BUY	$22.22 - $36.67 $63,971 - $105,572	2,879 Added 7.18%	42,975 $1.13 Million
Q4 2024 May 29, 2025	SELL	$33.39 - $57.5 $96,129 - $165,542	-2,879 Reduced 6.7%	40,096 $1.35 Million
Q4 2024 Jan 30, 2025	SELL	$33.39 - $57.5 $31,086 - $53,532	-931 Reduced 2.27%	40,096 $1.35 Million
Q3 2024 Nov 12, 2024	SELL	$20.85 - $46.47 $41,574 - $92,661	-1,994 Reduced 4.63%	41,027 $1.84 Million
Q2 2024 Aug 01, 2024	BUY	$10.0 - $21.64 $32,530 - $70,394	3,253 Added 8.18%	43,021 $898,000
Q1 2024 May 09, 2024	BUY	$9.3 - $13.23 $11,894 - $16,921	1,279 Added 3.32%	39,768 $526,000
Q4 2023 Feb 08, 2024	SELL	$8.1 - $16.36 $19,253 - $38,887	-2,377 Reduced 5.82%	38,489 $431,000
Q3 2023 Nov 09, 2023	BUY	$14.03 - $22.08 $102,517 - $161,338	7,307 Added 21.77%	40,866 $587,000
Q2 2023 Aug 08, 2023	BUY	$17.37 - $28.08 $582,919 - $942,336	33,559 New	33,559 $638,000
Q2 2021 Aug 05, 2021	SELL	$6.68 - $11.07 $107,741 - $178,548	-16,129 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$6.26 - $11.03 $3,693 - $6,507	-590 Reduced 3.53%	16,129 $109,000
Q4 2020 Feb 10, 2021	BUY	$4.76 - $6.93 $7,806 - $11,365	1,640 Added 10.88%	16,719 $115,000
Q3 2020 Nov 12, 2020	SELL	$4.71 - $7.36 $18,227 - $28,483	-3,870 Reduced 20.42%	15,079 $84,000
Q2 2020 Aug 13, 2020	BUY	$3.61 - $6.47 $68,405 - $122,600	18,949 New	18,949 $99,000

Others Institutions Holding HROW

# of Institutions

175

Shares Held

21.5M

Call Options Held

390K

Put Options Held

413K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $1.14B
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Harrow Health, Inc. Transaction History